can glp 1 affect your kidneys GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 receptor agonists in patients

The Phase 3 program, branded TRIUMPH, began reporting in 2026, and the early TRIUMPH-4 readout has been widely described in the trade literature as approaching 28.7% body weight reduction at the top dose over the trials primary endpoint window

Translated by SuperSmart

While not directly addressing the legitimacy of patient-specific compounding of GLP-1 products, FDA has sent a cautionary sign to 503A pharmacies operating in this space

Water is the best option for daily hydration

Many companies that require one offer free virtual consultations, with eligible patients potentially receiving approval within 24 hours

A recent study presents a novel nano-photosensitizer, named YBS-BMS NPs-RKC, which innovatively combines pH-responsive induction of immunogenic pyroptosis with immune checkpoint blockade (ICB)